SUMMARY Observations are reported on 14 patients with a clinical diagnosis of recurrent or chronic relapsing idiopathic inflammatory polyneuropathy of Guillain-Barre type. The results suggest the possibility of a disease susceptibility gene for this disorder associated with the HLA-A1, -B8, -DRw3, and -Dw3 haplotype.
disease, they are characterised by predominantly motor involvement, severely reduced nerve conduction velocity, and raised cerebrospinal fluid protein levels. The histological features are similar in the acute and both the chronic relapsing (Thomas et al., 1969) and chronic progressive (Dyck et al., 1975) forms, with extensive segmental demyelination in peripheral nerve trunks and spinal roots associated with focal accumulations of mononuclear cells. It has, therefore, been suggested that these disorders are variants of the same condition (Thomas et al., 1969). There are close parallels between experimental allergic neuritis (EAN) and the Guillain-Barre syndrome. Experimental allergic neuritis probably represents a cell-mediated, delayed hypersensitivity reaction to peripheral nerve antigens and provides a useful animal model for the Guillain-Barre syndrome (Arnason, 1975) . The usual pattern in EAN is an acute monophasic illness, but a small proportion of animals pursue a chronic progressive or relapsing course (Pollard et al., 1975) . It is thus possible that the latter parallel the chronic relapsing human cases.
The HLA associations that have been established for a number of autoimmune disorders prompted us to examine the situation in idiopathic demyelinating neuropathy. In 59 cases of the GuillainBarre syndrome of acute onset, we found no deviation in the frequency of HLA-A, -B or -C antigens (Adams et al., 1977) . The lack of any such association has since been confirmed in two further reports (Latovitski et al., 1978; Stewart et al., 1978) .
In this communication, we present preliminary results on the distribution of HLA-A, -B, -C, -DR, and -D locus antigens in a series of patients with recurrent or chronic relapsing idiopathic inflammatory polyneuropathy.
Results
The observations were made on 14 cases diagnosed as recurrent or chronic relapsing idiopathic inflammatory polyneuropathy on the basis of their clinical features, raised CSF protein level, nerve conduction studies, and, in some instances, sural or radial nerve biopsy. It was difficult to distinguish recurrent cases-that is, with recovery between episodes-from chronic relapsing cases without recovery between exacerbations. Both variants have, therefore, been included together. All cases had at least two relapses.
Eight HLA-DR antigens were defined by a panel of selected antisera used in the 1977 Histocompatibility Workshop . The HLA-D specificities were identified by the use of homozygous typing cells accredited in the 1975 184 and 1977 Histocompatibility Workshops (Thorsby and Piazza, 1975; Festenstein et al., 1978 ). Each patient was tested at least twice for eight specificities (HLA-Dwl-Dw8), and at least two Dw3 cells were incorporated in each expenrment.
The HLA-A, -B, -C, -DR, and -D phenotypes for each patient are given in Table 1 . There was a significant increase (P<0.02) in the frequency of HLA-B8 (50%) as compared with 25% in a control panel of 571 individuals (Adams et al., 1977) . The frequency of the HLA-D region antigens is given in Table 2 . When compared with the frequencies in 351 European Caucasoids, there was a significant increase in HLA-DRw3 (50% versus 17%, P<0.05). The frequency of HLA-Dw3 was also increased (37% versus 21%, P<0.05). Although it was not possible to establish the individual haplotypes without family segregation studies, it is interesting to note that of the five individuals who were HLA-A1, -B8, and -Dw3, three were also HLA-DRw3. However, both HLA -Dw3 and -DRw3 specificities are among those that are not yet clearly defined Festenstein et al., 1978) . HLA-B8, which has the strongest association, is a well-established specificity. Several sera that are used in the definition of these two antigens which are difficult to define may also give positive reactions in the presence of homozygous HLA-A2 cells (Wolf et al., 1975) . Thus the apparent A locus phenotype A2, Aw3O/31 may in fact be HLA-A-2, -2.
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